Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 1

Conditions

Anus Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Squamous Intraepithelial Lesions 1Recurrence 1Penile Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Anal Canal Carcinoma 1

Interventions

Light Coagulation 3Watchful Waiting 2Observation 2VGX-3100 1Polymerase Chain Reaction 1Laser Therapy 1Imiquimod 1Gene Expression Profiling 1Fluorouracil 1DNA Methylation 1Cidofovir 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Intraepithelial Lesions × VGX-3100 × Gastrointestinal × Clear all
NCT03499795 2023-07-14

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Inovio Pharmaceuticals

Phase 2 Completed
23 enrolled 19 charts
GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡